Cargando…
Targeting Fibrosis Pathways in Alport Syndrome—Is it Too Late?
Autor principal: | Rheault, Michelle N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371376/ https://www.ncbi.nlm.nih.gov/pubmed/37229728 http://dx.doi.org/10.34067/KID.0000000000000136 |
Ejemplares similares
-
Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011) -
Diagnosis of cystic fibrosis-related diabetes: too early or too late?
por: Sovtic, Aleksandar
Publicado: (2022) -
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012) -
Genetic diagnosis of Alport syndrome
por: Cheong, Hae Il
Publicado: (2019) -
COVID-19: too little, too late?
por: The Lancet
Publicado: (2020)